The HYM Study has now finished recruitment.
Human papillomavirus (HPV) is a common sexually-transmitted virus that is usually harmless but can in some rare circumstances cause disease in men and women. The Western Pacific Regional Reference Laboratory of the HPV LabNet, based at The Royal Women’s Hospital in Melbourne, is conducting a study to find out how common HPV is in young Australian men, and if there are any things that increase a man’s risk of having HPV.
If you are an existing participant and would like to get in touch with the research team, please contact us.
Why are we doing this study?
- We are conducting this study to find out how common human papillomavirus (HPV) is in young men, and factors that are associated with having HPV.
HPV is usually harmless but can in certain circumstances lead to genital warts, cervical cancer in women and, rarely, some forms of cancer in men. Since 2006 a vaccine has been offered to high school girls to protect them from infection. In 2013, the Australian government extended the HPV vaccination program to include high school boys.
We hope to use the information we are collecting to see if there is a decrease in HPV in young men after the vaccination program. To do this, we first need to measure HPV in young males before the vaccination program was introduced.
Who is doing and funding this study?
- This research is funded by The Department of Microbiology and Infectious Diseases at The Royal Women’s Hospital, Melbourne, through a grant from the Australian government Department of Health. We are a team of experienced doctors and scientists with an interest in sexual health, HPV and associated cancers.
The ethical aspects of this research project have been approved by the Human Research Ethics Committee of The Royal Women’s Hospital.